Literature DB >> 10528071

Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer.

K J Brodbeck1, J R DesNoyer, A J McHugh.   

Abstract

The role of solvent properties and bath-side composition on the phase inversion dynamics and in vitro protein release kinetics of polylactic-co-glycolic acid (PLGA) solutions has been examined using dark ground imaging, in vitro release rate, and SEM techniques. Thermodynamic phase diagrams for three model systems (PLGA in 1-methyl-2-pyrrolidinone (NMP), triacetin, and ethyl benzoate) suggest two general classes of precipitation behavior, depending on the relative solvent strength and water miscibility. Drug release from the NMP-based system is primarily governed by the dynamics of phase inversion and exhibits a distinct burst region followed by a much slower release. Alternatively, depots with low solvent/water affinity (PLGA in triacetin or ethyl benzoate) undergo much slower phase inversion, resulting in a less porous, more fluid, two-phase structure that also releases protein more uniformly. Addition of a small chain triglyceride or organic salt to the aqueous receptor bath also evokes a significant increase in the mass transfer rate of protein from the low solvent/non-solvent affinity depots. An interpretation of these results in terms of a qualitative model for the protein release mechanism is also given.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528071     DOI: 10.1016/s0168-3659(99)00159-5

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  30 in total

1.  Sustained release of human growth hormone from PLGA solution depots.

Authors:  K J Brodbeck; S Pushpala; A J McHugh
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

2.  Effect of injection site on in situ implant formation and drug release in vivo.

Authors:  Ravi B Patel; Luis Solorio; Hanping Wu; Tianyi Krupka; Agata A Exner
Journal:  J Control Release       Date:  2010-08-20       Impact factor: 9.776

3.  The Effect of Additives on the Behavior of Phase Sensitive In Situ Forming Implants.

Authors:  Luis Solorio; Divya Sundarapandiyan; Alex Olear; Agata A Exner
Journal:  J Pharm Sci       Date:  2015-07-14       Impact factor: 3.534

Review 4.  Advances in image-guided intratumoral drug delivery techniques.

Authors:  Luis Solorio; Ravi B Patel; Hanping Wu; Tianyi Krupka; Agata A Exner
Journal:  Ther Deliv       Date:  2010-08

Review 5.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

6.  Macroporous acrylamide phantoms improve prediction of in vivo performance of in situ forming implants.

Authors:  Christopher Hernandez; Natalia Gawlik; Monika Goss; Haoyan Zhou; Selva Jeganathan; Danielle Gilbert; Agata A Exner
Journal:  J Control Release       Date:  2016-10-11       Impact factor: 9.776

7.  In situ forming implants exposed to ultrasound enhance therapeutic efficacy in subcutaneous murine tumors.

Authors:  Selva Jeganathan; Emily Budziszewski; Peter Bielecki; Michael C Kolios; Agata A Exner
Journal:  J Control Release       Date:  2020-05-07       Impact factor: 9.776

8.  Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.

Authors:  Luis Solorio; Hanping Wu; Christopher Hernandez; Mihika Gangolli; Agata A Exner
Journal:  Ther Deliv       Date:  2016

9.  Effect of additives on the release of a model protein from PLGA microspheres.

Authors:  F Kang; J Singh
Journal:  AAPS PharmSciTech       Date:  2001-12-17       Impact factor: 3.246

10.  Development of an enhanced formulation for delivering sustained release of buprenorphine hydrochloride.

Authors:  S Koocheki; S S Madaeni; P Niroomandi
Journal:  Saudi Pharm J       Date:  2011-05-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.